FDA Inspection 1253117 — Laboratorio Italiano Biochimico Farmaceutico Lisapharma SPA
The FDA completed an inspection of Laboratorio Italiano Biochimico Farmaceutico Lisapharma SPA on September 26, 2023 in Erba. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 26, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Erba (Italy)